The Growth in the market is largely driven by the increasing adoption of minimally invasive surgeries over open surgeries, the rising prevalence of colorectal cancer, the increasing number of laparoscopic bariatric procedures, and technological advancements in laparoscopy. On the other hand, reduced Medicare payments to healthcare providers in the US and the dearth of trained professionals in laparoscopy are expected to restrain the overall market growth.
The COVID-19 pandemic has resulted in a global healthcare crisis, causing a shift in healthcare delivery in most regions. Surgeons and patients visiting hospitals for various treatments are at increased risk of contracting COVID-19. According to researchers at Indiana University, healthcare visits decreased by around 40% in the first six weeks of the pandemic in the US (from early March to mid-April). The volume of surgeries decreased by around 70–80% in the first half of 2020. This has severely impacted healthcare revenue, as elective surgeries account for ~20% of the total healthcare revenue in countries such as the US. This had a negative impact on the surgical devices market, including the laparoscopic instruments market, in 2020.